Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Oxford BioMedica plc (GB:OXB)
LSE:OXB
Holding GB:OXB?
Track your performance easily
See the Price Targets and Ratings of:
OXB Analyst Ratings
Moderate Buy
1 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
OXB Stock 12 Month Forecast
Average Price Target
401.73p
▲(18.50% Upside)
| Highest Price Target401.62p | Average Price Target401.73p | Lowest Price Target401.62p |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Stifel Nicolaus
Reiterated
08/08/24
RBC Capital
740p
Buy
118.29%
Upside
Reiterated
05/21/24
RBC Capital Sticks to Their Buy Rating for Oxford BioMedica (OXBDF)
J.P. Morgan
2.1p→305p
Hold
-10.03%
Downside
Reiterated
05/09/24
Oxford Biomedica (OXB:LN) (OXBDF) PT Raised to GBP3.05 at JPMorganJPMorgan analyst James Gordon raised the price target on Oxford Biomedica (OXB:LN) (OTC: OXBDF) to GBP3.05 (from GBP2.10) while maintaining a Neutral rating.
Investec
366p
Buy
7.96%
Upside
Upgraded
05/08/24
Oxford Biomedica upgraded to Buy from Hold at InvestecOxford Biomedica upgraded to Buy from Hold at Investec
Edward Thomason
Not Ranked
Panmure Liberum
350p→310p
Hold
-8.55%
Downside
Reiterated
09/26/23
Unknown Analyst
Not Ranked
DEL_Numis
180p
Hold
-46.90%
Downside
Reiterated
03/20/24
Best Analysts Covering Oxford BioMedica
Which Analyst Should I Follow If I Want to Buy GB:OXB and Sell After:
1 Month
xxx
Success Rate
7/18 ratings generated profit
Average Return
-1.03%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 38.89% of your transactions generating a profit, with an average return of -1.03% per trade.
3 Months
xxx
Success Rate
10/18 ratings generated profit
Average Return
+0.42%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 55.56% of your transactions generating a profit, with an average return of +0.42% per trade.
1 Year
Success Rate
7/18 ratings generated profit
Average Return
-2.20%
reiterated a buy rating 4 months ago
Copying Charles Weston's trades and holding each position for 1 Year would result in 38.89% of your transactions generating a profit, with an average return of -2.20% per trade.
2 Years
xxx
Success Rate
4/18 ratings generated profit
Average Return
-32.36%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 22.22% of your transactions generating a profit, with an average return of -32.36% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
OXB Analyst Recommendation Trends
Rating
Dec 23
Mar 24
Apr 24
May 24
Aug 24
Strong Buy
1
1
2
4
4
Buy
0
0
1
1
1
Hold
6
4
3
3
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
7
5
6
8
7
Each month's total comprises the sum of three months' worth of ratings.
OXB Financial Forecast
OXB Stock Forecast FAQ
What is GB:OXB’s average 12-month price target, according to analysts?
Based on analyst ratings, Oxford BioMedica plc’s 12-month average price target is 401.73p.
What is GB:OXB’s upside potential, based on the analysts’ average price target?
Oxford BioMedica plc has 18.50% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Oxford BioMedica plc a Buy, Sell or Hold?
Oxford BioMedica plc has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
What is Oxford BioMedica plc’s share price target?
The average share price target for Oxford BioMedica plc is 401.73p. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is 401.62p ,and the lowest forecast is 401.62p. The average share price target represents 18.50% Increase from the current price of 339p.
The highest analyst share price target is 401.62p ,and the lowest forecast is 401.62p. The average share price target represents 18.50% Increase from the current price of 339p.
What do analysts say about Oxford BioMedica plc?
Oxford BioMedica plc’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
How can I buy shares of Oxford BioMedica plc?
To buy shares of GB:OXB, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.